Dr. Yu Hongping
Co - founder of senior VP of drug chemistry
Pharmaceuticals
Abbisko Therapeutics
China
Biography
 Dr. Yu Hongping has nearly 15 years of experience in the development of new drugs in large pharmaceutical companies. During this period he led and participated in more than ten new drug research and development projects, across multiple treatment areas. Several of these projects go to post-development and clinical research. Prior to co-creation and reputation, Dr. Yu Hongping served as vice president of pharmaceutical chemistry at Shanghai Hansen Biomedical Technology Co., Ltd. (Haosen Group's new drug research and development center), established a drug chemistry team, targeting EGFR, FXR, NS5A / B and other targets, Found and developed a new generation of drug candidate compounds. Prior to that, he had served as Deputy Director of Pharmaceutical Chemistry at Novartis Pharmaceuticals, and was a Senior Fellow at Merck Pharmaceuticals.
Research Interest
Business, Management, Finance, Pharmaceuticals, Chemistry, Pharmacology
